AstraZeneca Pharma India's Managing Director Gagandeep Singh Bedi Resigns; Appoints Sanjeev Panchal As New MD
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
New Delhi, December 14: AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director. One Shot of Pfizer, AstraZeneca COVID-19 Vaccine Offers 60% Protection Against Coronavirus, Says Study.
The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years with effect from January 1, 2023. AstraZeneca COVID-19 Vaccine Protection May Last a Lifetime, Says Study.
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)